Literature DB >> 16175249

A review of the use of methadone for the treatment of chronic noncancer pain.

Mary E Lynch1.   

Abstract

Methadone, although having been available for approximately half a century, is now receiving increasing attention in the management of chronic pain. This is due to recent research showing that methadone exhibits at least three different mechanisms of action including potent opioid agonism, N-methyl-D-aspartate antagonism and monoaminergic effects. This, along with methadone's excellent oral and rectal absorption, high bioavailability, long duration of action and low cost, make it a very attractive option for the treatment of chronic pain. The disadvantages of significant interindividual variation in pharmacokinetics, graduated dose equivalency ratios based on prerotation opioid dose when switching from another opioid, and the requirement for special exemption for prescribing methadone make it more complicated to use. The present review is intended to educate physicians interested in adding methadone to their armamentarium for assisting patients with moderate to severe pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175249     DOI: 10.1155/2005/286713

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  19 in total

1.  Methadone use in children and young adults at a cancer center: a retrospective study.

Authors:  Doralina L Anghelescu; Lane G Faughnan; Gisele M Hankins; Deborah A Ward; Linda L Oakes
Journal:  J Opioid Manag       Date:  2011 Sep-Oct

2.  Pharmacokinetics of a new immediate-release methadone tablet formulation with decreased in vitro solubility.

Authors:  Robert K Vinson
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

3.  The 2010 Annual Conference of the Canadian Pain Society.

Authors: 
Journal:  Pain Res Manag       Date:  2010 Mar-Apr       Impact factor: 3.037

Review 4.  Methadone for treatment of cancer pain.

Authors:  John Bryson; Anoo Tamber; Dori Seccareccia; Camilla Zimmermann
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 5.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

6.  Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience.

Authors:  Doralina L Anghelescu; Linda L Oakes; Gisele M Hankins
Journal:  Pain Manag Nurs       Date:  2010-09-20       Impact factor: 1.929

Review 7.  Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.

Authors:  Alex Mu; Erica Weinberg; Dwight E Moulin; Hance Clarke
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

8.  Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Authors:  D E Moulin; A J Clark; I Gilron; M A Ware; C P N Watson; B J Sessle; T Coderre; P K Morley-Forster; J Stinson; A Boulanger; P Peng; G A Finley; P Taenzer; P Squire; D Dion; A Cholkan; A Gilani; A Gordon; J Henry; R Jovey; M Lynch; A Mailis-Gagnon; A Panju; G B Rollman; A Velly
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

9.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

10.  Pharmacologic management of chronic pain.

Authors:  Hue Jung Park; Dong Eon Moon
Journal:  Korean J Pain       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.